DK209090A - Monoklont antistof mod protein c - Google Patents

Monoklont antistof mod protein c Download PDF

Info

Publication number
DK209090A
DK209090A DK209090A DK209090A DK209090A DK 209090 A DK209090 A DK 209090A DK 209090 A DK209090 A DK 209090A DK 209090 A DK209090 A DK 209090A DK 209090 A DK209090 A DK 209090A
Authority
DK
Denmark
Prior art keywords
protein
antibody
activation
isolation
peptide
Prior art date
Application number
DK209090A
Other languages
English (en)
Other versions
DK171826B1 (da
DK209090D0 (da
Inventor
Charles T Esmon
Naomi L Esmon
Original Assignee
Oklahoma Med Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oklahoma Med Res Found filed Critical Oklahoma Med Res Found
Publication of DK209090A publication Critical patent/DK209090A/da
Publication of DK209090D0 publication Critical patent/DK209090D0/da
Application granted granted Critical
Publication of DK171826B1 publication Critical patent/DK171826B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/04—Phospholipids, i.e. phosphoglycerides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK209090A 1988-12-30 1990-08-30 Ca2+-afhængigt monoklonalt antistof mod protein C, hybridomacellelinie til produktion af antistoffet, fremgangsmåde til isolation af protein C, fremgangsmåde til fremstilling af antistoffet og polypeptid til brug ved fremgangsmåden DK171826B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US29244788A 1988-12-30 1988-12-30
US29244788 1988-12-30
US8905851 1989-12-28
PCT/US1989/005851 WO1990007524A1 (en) 1988-12-30 1989-12-28 Monoclonal antibody against protein c

Publications (3)

Publication Number Publication Date
DK209090A true DK209090A (da) 1990-08-30
DK209090D0 DK209090D0 (da) 1990-08-30
DK171826B1 DK171826B1 (da) 1997-06-23

Family

ID=23124711

Family Applications (1)

Application Number Title Priority Date Filing Date
DK209090A DK171826B1 (da) 1988-12-30 1990-08-30 Ca2+-afhængigt monoklonalt antistof mod protein C, hybridomacellelinie til produktion af antistoffet, fremgangsmåde til isolation af protein C, fremgangsmåde til fremstilling af antistoffet og polypeptid til brug ved fremgangsmåden

Country Status (11)

Country Link
EP (1) EP0407544B1 (da)
JP (1) JP2559537B2 (da)
KR (1) KR940002033B1 (da)
AT (1) ATE122057T1 (da)
AU (2) AU641634B2 (da)
CA (1) CA2006684C (da)
DE (1) DE68922491T2 (da)
DK (1) DK171826B1 (da)
ES (1) ES2074562T3 (da)
FI (1) FI101476B (da)
WO (1) WO1990007524A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298599A (en) * 1988-12-30 1994-03-29 Oklahoma Medical Research Foundation Expression and purification of recombinant soluble tissue factor
AT402262B (de) * 1991-06-20 1997-03-25 Immuno Ag Arzneimittel enthaltend aktiviertes protein c
AU4784693A (en) * 1992-07-24 1994-02-14 Oklahoma Medical Research Foundation Blockade of protein c activation reduces microvascular surgical blood loss
DE69329682T2 (de) * 1992-08-27 2001-05-17 Stichting Sanquin Bloedvoorziening, Amsterdam Antikoerper spezifisch fur ein haemostatisches protein; seine verwendung zur isolation von intaktem protein; haemostatische zusammensetzungen ohne proteolytische spaltprodukte des proteins
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
US5532136A (en) * 1993-06-22 1996-07-02 Bionebraska, Inc. Monoclonal antibody assay and kit for detecting metal cations in body fluids
ATE213639T1 (de) * 1993-07-09 2002-03-15 Avant Immunotherapeutics Inc Proteinreinigung
HRP940645A2 (en) * 1993-10-06 1996-12-31 Immuno Ag Process for virus deactivation in the presence of polyalkylene glycol and the pharmaceutical preparation thus obtained
DE69535855D1 (de) * 1994-06-10 2008-11-20 Oklahoma Med Res Found Calciumbindende rekombinante antikörper gegen protein c
TW200407335A (en) * 2002-07-22 2004-05-16 Chugai Pharmaceutical Co Ltd Non-neutralizing antibody to inhibit the inactivation of activated protein C
EP2275443B1 (en) 2008-04-11 2015-12-02 Chugai Seiyaku Kabushiki Kaisha Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
WO2012073992A1 (ja) 2010-11-30 2012-06-07 中外製薬株式会社 複数分子の抗原に繰り返し結合する抗原結合分子
KR102147548B1 (ko) 2011-02-25 2020-08-24 추가이 세이야쿠 가부시키가이샤 ＦｃγＲＩＩｂ 특이적 Ｆｃ 항체
WO2013047748A1 (ja) 2011-09-30 2013-04-04 中外製薬株式会社 複数の生理活性を有する抗原の消失を促進する抗原結合分子
EP3047857A4 (en) * 2013-09-20 2017-08-09 Chugai Seiyaku Kabushiki Kaisha Treatment for hemorrhagic diseases by anti-protein-c antibody
UA127961C2 (uk) 2014-12-19 2024-02-28 Чугей Сейяку Кабусікі Кайся Антитіло до латентного міостатину
EP3233921B1 (en) 2014-12-19 2021-09-29 Chugai Seiyaku Kabushiki Kaisha Anti-c5 antibodies and methods of use
US11359009B2 (en) 2015-12-25 2022-06-14 Chugai Seiyaku Kabushiki Kaisha Anti-myostatin antibodies and methods of use
TWI831965B (zh) 2016-08-05 2024-02-11 日商中外製藥股份有限公司 Il-8相關疾病之治療用或預防用組成物
WO2018139623A1 (en) 2017-01-30 2018-08-02 Chugai Seiyaku Kabushiki Kaisha Anti-sclerostin antibodies and methods of use

Also Published As

Publication number Publication date
AU641634B2 (en) 1993-09-30
DE68922491T2 (de) 1995-11-09
WO1990007524A1 (en) 1990-07-12
FI904262A0 (fi) 1990-08-29
ATE122057T1 (de) 1995-05-15
DE68922491D1 (de) 1995-06-08
EP0407544A1 (en) 1991-01-16
FI101476B1 (fi) 1998-06-30
ES2074562T3 (es) 1995-09-16
AU669540B2 (en) 1996-06-13
KR910700266A (ko) 1991-03-14
DK171826B1 (da) 1997-06-23
JP2559537B2 (ja) 1996-12-04
KR940002033B1 (ko) 1994-03-14
CA2006684A1 (en) 1990-06-30
AU4968390A (en) 1990-08-01
CA2006684C (en) 1996-12-17
AU4422893A (en) 1994-01-27
FI101476B (fi) 1998-06-30
JPH03504332A (ja) 1991-09-26
DK209090D0 (da) 1990-08-30
EP0407544B1 (en) 1995-05-03

Similar Documents

Publication Publication Date Title
DK209090A (da) Monoklont antistof mod protein c
Fearn et al. EGF receptor affinity is regulated by intracellular calcium and protein kinase C
EP0930366A3 (en) Binding domains in delta proteins
KITAHARA et al. Large-scale purification of porcine calpain I and calpain II and comparison of proteolytic fragments of their subunits
RU94045919A (ru) Антитела, клетки, полипептид, днк векторы, способ получения полипептида, способ получения антитела, фармацевтическая композиция
Xiao et al. Phosphorylation of HMG‐I by Protein Kinase C Attenuates Its Binding Affinity to the Promoter Regions of Protein Kinase C γ and Neurogranin/RC3 Genes
DE69435020D1 (en) Protein-tyrosin-phosphatase ptp-s31
WO1994003611A3 (en) Ptp-d subfamily of protein tyrosine phosphatases
DE69535855D1 (de) Calciumbindende rekombinante antikörper gegen protein c
Cesbron et al. Human coumarin prothrombin
Imamura et al. A novel nonmuscle alpha-actinin. Purification and characterization of chicken lung alpha-actinin.
CA2285700C (en) Renin-active substance
Woodley et al. Specific identification of tissue kallikrein in exocrine tissues and in cell-free translation products with monoclonal antibodies
KR930002834B1 (ko) 항유로키나제 모노클론 항체 함유 면역흡착제 및 이를 사용하는 유로키나제 정제방법
Arlaud et al. Use of an IgG fragment prepared with particulate plasmin to study the C1 binding and activation
NO903788L (no) Monoklonalt antistoff mot protein c.
Werrbach-Perez et al. De novo synthesis of NGF subunits in S-180 mouse sarcoma cell line
Solomon et al. Affinity purification of antibodies using immobilized FB domain of protein A
Mannhalter Purification of plasma protein
DE3855007D1 (de) METHODE ZUR REINIGUNG REKOMBINANTER t-PA VON DEN IHREN ENTSPRECHENDEN WIRTSZELLPROTEINEN
Zibirre et al. Detection and localization of a cytoplasmic domain on the beta-subunit of Na+, K+-ATPase. A monoclonal antibody study.
Yasuda et al. Use of antibodies against synthetic peptides for analysis of molecular multiplicity: human deoxyribonuclease I polymorphism
Yoshino et al. Characterization of the lateral interaction between human erythrocyte spectrin subunits
Shupp-Byrne et al. “Embryonic” Collagen (Type I Trimer) α1-Chains are Genetically Distinct from Type I Collagens α1-Chains
Ratliff et al. Immunologic evidence for structural homology between the release factors of Escherichia coli

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired